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OBJECTIVES We studied whether assessment of endothelium-dependent vasomotion (EDV) with brachial
artery ultrasound (BAUS) imaging predicts the presence or absence of coronary artery disease
(CAD) as defined by exercise myocardial perfusion imaging (ExMPI).
BACKGROUND Abnormalities in EDV can be detected in arteries before the development of overt
atherosclerosis, and its presence may predict poor long-term prognosis. Brachial artery
ultrasound during reactive hyperemia is a noninvasive method of assessing peripheral EDV.
METHODS Clinically-indicated ExMPI along with BAUS were performed in 94 subjects (43 women, 51
men). Coronary artery disease was defined by myocardial ischemia or infarction on single
photon emission computed tomography images. Flow-mediated dilation (FMD) after upper
arm occlusion was defined as the percent change in arterial diameter during reactive
hyperemia relative to the baseline.
RESULTS Subjects with CAD by ExMPI (n  23) had a lower FMD (6.3  0.7%) than those without
CAD by ExMPI (n  71) (10.5  0.6%; p  0.0004). Flow-mediated dilation was highly
predictive for CAD with an odds ratio of 1.32 for each percent decrease in FMD (p 0.001).
Based on a receiver-operator analysis, an FMD of 10% was used as a cut-point for further
analysis. Twenty-one of 23 subjects who were positive for ExMPI had an FMD 10%
(sensitivity 91%), whereas only two of 40 subjects with an FMD 10% were ExMPI-positive
(negative predictive value: 95%). There was a correlation between the number of cardiac risk
factors and FMD. Individuals with an FMD 10% exercised for a shorter duration than
those with an FMD 10% (456  24 vs. 544  31 s, respectively; p  0.02).
CONCLUSIONS Assessment of EDV with BAUS has a high sensitivity and an excellent negative predictive
value for CAD and, thus, has the potential for use as a screening tool to exclude CAD in
low-risk subjects. Further standardization of BAUS is required, however, before specific
cut-points for excluding CAD can be established. (J Am Coll Cardiol 2001;38:1843–9)
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Impaired endothelium-dependent vasomotion (EDV) is
a diffuse disease process resulting in abnormal regulation
of blood vessel tone and the loss of several atheroprotec-
tive effects of the normal endothelium (1). Abnormal
EDV can be detected in the coronary circulation before
the development of angiographically significant athero-
sclerotic plaque (2), and this has been shown to be
associated with an increased risk of future cardiac events
(3,4). Although assessment of coronary artery endothelial
function has the advantage of examining the vascular bed
with the greatest clinical relevance, it requires a special-
ized invasive procedure that is costly and not without
risk.
In addition to the coronary circulation, endothelial
dysfunction occurs concurrently in peripheral arteries,
and the assessment of peripheral EDV provides an
opportunity to evaluate larger patient populations in a
noninvasive fashion (5). Brachial artery ultrasound
(BAUS) imaging during reactive hyperemia is a widely
used tool for quantifying EDV (6), and impaired periph-
eral endothelial function may also be a marker of in-
creased future cardiovascular risk (7). Brachial artery
ultrasound can detect abnormalities in EDV in subjects at
risk for atherosclerosis (8), and medical interventions and
lifestyle changes that reduce coronary artery disease
(CAD) risk are associated with improved peripheral
endothelial function (9 –12).
Previous studies have shown a modest correlation
between abnormalities in peripheral artery EDV detected
by BAUS and coronary artery EDV defined by coronary
angiography with vasoactive medications (13,14). A ma-
jority of patients presenting for cardiovascular evaluation,
however, do not undergo invasive vascular testing. There-
fore, we evaluated whether flow-mediated dilation
(FMD) of the brachial artery predicts the presence or
absence of CAD defined by exercise myocardial perfusion
imaging (ExMPI) in low- to intermediate-risk subjects.
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METHODS
Patient population. Consecutive subjects over 18 years of
age without prior history of CAD who presented for
clinically indicated ExMPI at the New England Medical
Center (Boston, Massachusetts) were recruited and enrolled
in this study. All subjects gave their written informed
consent to participate, and the protocol was approved by the
institutional Human Investigation Review Committee.
Subjects were instructed to fast overnight, to refrain from
smoking, ingesting alcohol or caffeine on the day of testing
and to hold any vasoactive medications for 12 h before the
imaging studies. Exclusion criteria included an inability to
exercise, recent myocardial infarction or unstable angina
(within three months), congestive heart failure or significant
valvular heart disease.
The presence or absence of the following cardiovascular
risk factors was assessed in each subject: male gender,
hypertension (systolic blood pressure 140 mm Hg or
diastolic blood pressure 90 mm Hg or being on an
antihypertensive medication), hyperlipidemia (total serum
cholesterol 220 mg/dl or taking lipid-lowering medica-
tion), diabetes mellitus (treated with an oral hypoglycemic
agent or insulin or having fasting glucose levels 140
mg/dl), family history of CAD (having first or second
degree relatives with premature cardiovascular disease),
postmenopause and smoking (having smoked at least five
cigarettes per day within the last month).
Stress testing protocol. Subjects performed a symptom-
limited treadmill test utilizing a Bruce exercise protocol under
standard supervision and continuous electrocardiographic
monitoring. Subjects received intravenous technetium-99m
sestamibi for stress perfusion imaging 1 to 2 min before the
completion of exercise. Exercise stress images were acquired
approximately 30 min after the completion of exercise.
Gated single photon emission computed tomography
(SPECT) imaging was also performed at this time for
analysis of left ventricular function (expressed as left ven-
tricular ejection fraction [LVEF]). Resting perfusion images
were obtained before the exercise portion of the test. The
SPECT images were analyzed by readers blinded to the
study protocol and BAUS results, and were considered
positive if perfusion abnormalities were detected (myocar-
dial ischemia or infarction) and negative if no perfusion
abnormalities were found.
Endothelial function testing. At least 2 h after comple-
tion of the ExMPI, BAUS testing was performed after a
protocol (11) similar to that described by Celermajer et al.
(15). Longitudinal brachial artery images were obtained
with a high-resolution (10 MHz) linear-array vascular
transducer (General Electric, Vingmed, System Five,
Horten, Norway). Subjects were studied under quiet con-
ditions while they were in the supine position in a
temperature-controlled room. After a 10-min equilibrium
period, baseline two-dimensional images of the right bra-
chial artery were obtained approximately 2 cm above the
antecubital fossa. A blood pressure cuff (Hokanson, Belle-
vue, Washington) placed proximal to the imaging trans-
ducer on the upper arm was inflated to suprasystolic pressure
for exactly 5 min. The vessel was imaged continuously for
1 min after release of occlusion, and reactive hyperemia was
confirmed by pulse-wave Doppler interrogation. Baseline
resting brachial artery dimensions were again obtained
10 min later. Subjects were given sublingual nitroglycerin
(400-g tablet), and the brachial artery was imaged for
5 min.
Endothelium-dependent vasomotion was determined by
the maximal brachial artery diameter after exactly 60 s of
reactive hyperemia compared with the baseline vessel diam-
eter and was expressed as percent FMD. Endothelium-
independent vasodilation was defined as the maximum bra-
chial artery diameter 5 min after administration of
nitroglycerin compared with the baseline vessel diameter
and was expressed as percent nitroglycerin-mediated dila-
tion (NMD). Brachial artery measurements were performed
with ultrasonic calipers by independent observers blinded to
the ExMPI results. Maximal end-diastolic brachial arterial
diameter was calculated within a 5-cm segment of the vessel
as the mean of five evenly spaced measurements of the
distance from the near to the far arterial wall along a line
perpendicular to the long axis of the artery. Mean intraob-
server and interobserver variability of brachial reactivity
measurements in our laboratory on normal volunteers were
1.9% and 2.8%, respectively.
Statistical analysis. A sample size of approximately 90
patients was chosen to provide 80% power (at   0.05) to
determine an absolute difference of 2% in FMD (16). Data
were entered into Excel and analyzed with SPSS (Version
10.0, SPSS, Inc., Chicago, Illinois). Data are expressed as
mean  SEM. Univariate analysis (t test) and Spearman
rank correlation were performed to demonstrate potential
associations with FMD. Multivariate stepwise logistic re-
gression analysis (forward selection with likelihood ratio
criterion for selection variables; 0.05 to enter, 0.10 to
remove) was used to estimate the relationship between
FMD and CAD and to evaluate for potential confounders,
including age, gender, presence of hypertension, hypercho-
lesterolemia, diabetes mellitus, tobacco use and family
history of premature CAD. A receiver operator character-
istics (ROC) curve was generated to determine the predic-
tive power of FMD for CAD. Multiple linear regression
Abbreviations and Acronyms
CAD  coronary artery disease
BAUS  brachial artery ultrasound
EDV  endothelium-dependent vasomotion
ExMPI  exercise myocardial perfusion imaging
FMD  flow-mediated dilation
LVEF  left ventricular ejection fraction
NMD  nitroglycerin-mediated vasodilation
ROC  receiver operator characteristic
SPECT  single photon emission computed tomography
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analysis was performed to estimate the relationships be-
tween FMD and exercise time and to evaluate and adjust for
possible confounding of age and cardiac risk factors. In all
analyses, a p value 0.05 was considered statistically signif-
icant.
RESULTS
Subject population. Ninety-four subjects (43 women, 51
men) with an average age of 56  1 year were enrolled and
completed both exercise stress imaging and peripheral
endothelial function testing. Characteristics of the study
population are listed in Table 1. There were no significant
differences in baseline characteristics between men and
women. Of the entire population, 45 subjects had a history
of hypertension; 9 had diabetes mellitus, and 45 had
hypercholesterolemia. Most women (77%) were postmeno-
pausal, and 21% were taking hormone replacement therapy.
Subjects had an average total cholesterol of 207  5 mg/dl,
low-density lipoprotein cholesterol level of 122  6 mg/dl
and high-density lipoprotein cholesterol level of 51  2
mg/dl. The mean LVEF was 63  1%. The number of
patients taking the medications most commonly used by
study subjects is listed in Table 1.
Relationship between FMD and CAD. Flow-mediated
dilation was significantly lower (6.3  0.7%) in the 23
subjects with a positive ExMPI for CAD compared with the
71 subjects with no evidence of CAD by SPECT imaging
(10.5  0.6%; p  0.0004) (Fig. 1, Table 2). Endothelium-
independent vasomotion was not statistically different be-
tween the positive and negative ExMPI groups (NMD:
16.8  1.8% vs. 18.6  0.9%, respectively). There were no
significant differences in baseline brachial artery dimensions
between the two groups (Table 2). Sensitivity and specific-
ity, along with positive and negative predictive values, of
BAUS for detection of CAD were analyzed at various FMD
cut-points (Table 3). For an FMD cut-point of 6%, the
sensitivity was limited while the specificity was relatively
high (43% vs. 80%, respectively) with a negative predictive
value of 81%. For an FMD cut-point of 14%, the sensitivity
improved significantly while the specificity decreased (100%
vs. 34%, respectively), and the negative predictive value
improved to 100%. An ROC curve examining the ability of
FMD to predict CAD yielded an area under the curve of
0.75 (p 0.001) (Fig. 2). Based on these analyses, an FMD
of 10% was chosen as a cut-point for further analysis as this
maximized the negative predictive value and had the least
impact on sensitivity.
Forty subjects had an FMD 10%, while 54 had an
FMD 10%. Twenty-one of 23 subjects with a positive
ExMPI had an FMD 10% (sensitivity 91%). Further-
more, only two of 40 subjects with an FMD 10% had a
positive ExMPI, resulting in a negative predictive value of
95%. Thus, 39% of subjects with an FMD 10% had a
positive ExMPI, whereas only 5% of subjects with an FMD
10% had CAD by nuclear imaging (Fig. 3).
Relationship between FMD and cardiac risk factors.
The average number of cardiac risk factors among all
subjects was 3.0  0.1. The number of cardiac risk factors
correlated with FMD (Spearman correlation coefficient
0.250; p  0.02). The 63 subjects with three or fewer
cardiac risk factors had a higher FMD (10.2  0.6%) than
the 31 subjects with more than three risk factors (8.1 
0.9%; p  0.04). Subjects without CAD who had an FMD
10% (n  33) had a greater number of risk factors
Table 1. Subject Population and Characteristics
Study Population
(n  94)
Men
(n  51)
Women
(n  43)
Age, yrs 56  2 56  2 56  2
Body mass index, kg/m2 29  1 28  1 29  1
Diabetes mellitus, n (%) 9 (10) 6 (12) 3 (7)
Hypertension, n (%) 45 (48) 22 (43) 23 (53)
Smoking
Active, n (%) 11 (12) 8 (16) 3 (7)
Former, n (%) 18 (19) 9 (18) 9 (21)
Postmenopausal women, n (%) 33 (77)
Family history of CAD, n (%) 46 (49) 23 (45) 23 (53)
Hypercholesterolemia, n (%) 43 (46) 25 (49) 18 (42)
Total cholesterol, mg/dl 207  5 203  8 211  7
LDL, mg/dl 122  6 125  7 117  9
HDL, mg/dl 51  2 47  2 56  3
LVEF (%) 63  1 58  1 69  1
Aspirin, n (%) 23 (24) 16 (31) 7 (16)
Beta-blocker, n (%) 20 (21) 12 (24) 8 (19)
Calcium-blocker, n (%) 14 (15) 6 (12) 8 (19)
ACE inhibitor, n (%) 22 (23) 14 (27) 8 (19)
Nitrates, n (%) 8 (9) 6 (12) 2 (5)
Statin, n (%) 27 (29) 16 (31) 11 (26)
ACE angiotensin-converting enzyme; CAD coronary artery disease; HDL high-density lipoprotein cholesterol; LDL
low-density lipoprotein cholesterol; LVEF  left ventricular ejection fraction; Statin  3-hydroxy-3-methylglutaryl coenzyme
A reductase inhibitor.
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compared with subjects without CAD who had an FMD
10% (n  38), though this did not achieve statistical
significance (3.1  0.2 vs. 2.6  0.2, respectively; p  0.1).
Flow-mediated dilation was independently highly predic-
tive for CAD with an odds ratio of 1.32 (95% confidence
intervals: 1.11 to 1.56) for each percent decrease in FMD
(p  0.001). Furthermore, male gender, hypercholesterol-
emia and diabetes mellitus were independent predictors of
CAD (p  0.01, 0.004 and 0.02, respectively). Multivariate
stepwise logistic regression analysis showed that the odds
ratio for FMD to predict CAD, adjusted for these variables,
was 1.29. Age, hypertension, smoking and family history of
CAD were not predictors of CAD in this analysis. Univar-
iate analysis revealed that gender, hypertension, hypercho-
lesterolemia and menopausal state were not predictors of
FMD, while age and diabetes mellitus were predictors (p 
0.02 and p  0.045, respectively).
Relationship between FMD and exercise parameters.
There was a significant relationship between FMD and
duration of exercise (Spearman correlation coefficient:
0.280; p  0.01). Length of treadmill exercise time during
ExMPI differed between those with an FMD 10% and
those with an FMD 10% (Table 4). Among all subjects,
individuals with FMD 10% had an average exercise time
of 456  24 compared with 544  31 s in subjects with
FMD 10% (p  0.02). This relationship was also statis-
tically significant for the subset of individuals with negative
ExMPI (444  29 vs. 547  32 s, p  0.02). Subjects with
a positive ExMPI exercised for a similar duration as those
with an FMD 10% in the negative ExMPI group (483 
37 vs. 444  29 s; p  NS). While age itself predicts
exercise time, multiple linear regression analysis revealed
that age was not a significant confounding variable for the
relationship between FMD and exercise time. There were
no significant differences in electrocardiographic criteria for
ischemia at peak exercise stress level between the groups.
DISCUSSION
Evaluation of EDV by high-resolution BAUS has evolved
into a widely used noninvasive method of determining
peripheral endothelial function in healthy individuals and in
patients with a variety of cardiovascular diseases. Previous
reports have noted a correlation between abnormalities in
FMD of the brachial artery and the presence of CAD by
coronary angiography (13,14). In this study, we compared
BAUS directly to exercise testing with SPECT imaging.
Exercise myocardial perfusion imaging is a highly validated
Table 2. Brachial Artery Ultrasound Measurements
ExMPI
Positive
ExMPI
Negative p Value
n 23 71
Baseline diameter (mm) 4.0  0.2 3.8  0.1 0.2
FMD diameter (mm) 4.3  0.2 4.2  0.1 0.7
%FMD 6.3  0.7 10.5  0.6 0.0004
Rebaseline diameter (mm) 4.0  0.2 3.8  0.1 0.3
NMD diameter (mm) 4.7  0.1 4.6  0.1 0.5
%NMD 16.8  1.8 18.6  0.9 0.4
Mean  standard error.
ExMPI  exercise myocardial perfusion imaging; FMD  flow-mediated
dilation; NMD  nitroglycerin-mediated dilation.
Figure 1. Endothelium-dependent and independent vasomotion. Flow-mediated dilation of the brachial artery during reactive hyperemia (endothelium-
dependent vasomotion) in subjects with negative exercise myocardial perfusion imaging (ExMPI) is significantly higher than it is in subjects with positive
ExMPI. Nitroglycerin-mediated dilation of the brachial artery (endothelium-independent vasomotion) is essentially unchanged between groups. Values are
expressed as mean  standard error. *p  0.0004.
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method for detecting CAD, quantifying myocardial isch-
emia and viability, determining prognosis and evaluating the
adequacy of revascularization (17–19). In addition to assess-
ing the presence and extent of CAD, this testing modality
provides physiologic data regarding myocardial perfusion
and exercise capacity. Among patients with suspected but
not known CAD, the percentage of individuals presenting
for nuclear stress testing who have a normal scan may be as
high as 75% (20). This is confirmed in this study where only
25% of subjects studied had a positive ExMPI for CAD.
Therefore, much interest lies in developing less expensive
noninvasive modalities for excluding CAD and assessing the
severity of cardiovascular risk.
Defining CAD risk by peripheral endothelial function
testing. The data presented above indicate that assessment
of peripheral endothelial function with BAUS may be
helpful in defining CAD risk in a low- to intermediate-risk
population. In this study, FMD was significantly lower in
individuals with CAD defined by nuclear imaging com-
pared with those with normal ExMPI. Furthermore, FMD
was an independent predictor of CAD. In the subjects
without CAD by ExMPI, however, approximately one-half
of the subjects had an FMD 10%, suggesting a relatively
limited specificity of this technique for detecting CAD. It is
important to note that abnormalities in EDV develop in
patients with cardiac risk factors before the development of
overt atherosclerosis (21). This study is consistent with
these observations. Subjects with normal nuclear scans but
with an FMD 10% had more cardiac risk factors than
those with an FMD 10%. In addition, the actual number
of cardiac risk factors had a modest correlation with endo-
thelial function. Subjects with few cardiac risk factors had a
larger FMD compared with those with numerous cardiac
Table 3. Flow-Mediated Dilation in Subjects Undergoing Exercise Myocardial Perfusion
Imaging
ExMPI() ExMPI() Sens Spec NPV PPV
FMD  6% 10 14
FMD  6% 13 57 43 80 81 42
FMD  8% 17 23
FMD  8% 6 48 74 68 89 43
FMD  10% 21 33
FMD  10% 2 38 91 54 95 39
FMD  12% 21 47
FMD  12% 2 24 91 34 92 31
FMD  14% 23 58
FMD  14% 0 13 100 18 100 28
ExMPI  exercise myocardial perfusion imaging; FMD  flow-mediated dilation; NPV  negative predictive value; PPV 
positive predictive value; Sens  sensitivity; Spec  specificity.
Figure 2. A receiver operator characteristics curve is shown examining the
ability of flow-mediated dilation (FMD) to predict coronary artery disease
defined by exercise myocardial perfusion imaging. An FMD of 10%
(arrow) was chosen as a cut-point for further analysis based on the high
sensitivity and negative predictive value. The area under the curve was 0.75
(p  0.001).
Figure 3. Flow diagram detailing the 94 subjects undergoing exercise
myocardial perfusion imaging. Subjects were divided based on a flow-
mediated dilation (FMD) cut-point of 10%. Of the 54 subjects with an
FMD 10%, 21 had positive exercise myocardial perfusion imaging
(ExMPI), while 33 had no evidence of coronary artery disease (CAD). The
sensitivity of an FMD 10% for CAD was 91%. Two of the 40 subjects
with an FMD 10% had CAD by ExMPI resulting in a negative
predictive value of 95%.
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risks. Thus, in a subset of patients without CAD by ExMPI,
FMD is impaired in association with cardiac risk factors,
thereby decreasing the specificity of this technique for
predicting the presence of CAD.
In contrast, normal FMD reflects a low cardiac risk factor
burden and is likely to be associated with a low risk of
developing CAD. We, therefore, examined the ability of
preserved FMD to predict the absence of CAD. We chose
an FMD value of 10% as a cut-point for analysis to optimize
the negative predictive value of BAUS to predict the
absence of CAD, while preserving the sensitivity of the test.
With this analysis, BAUS was found to be an effective test
for excluding CAD with a negative predictive value of 95%.
The relatively poor positive predictive value of BAUS likely
results from impaired endothelial function due to the
presence of cardiac risk factors. This decrease in peripheral
FMD may precede the development of atherosclerotic
stenoses that would be detected by ExMPI. Thus, abnormal
FMD detected by BAUS does not necessarily indicate that
CAD has developed, whereas normal EDV indicates a low
likelihood of advanced disease. Brachial artery ultrasound
may, therefore, be useful as a screening tool before ExMPI,
especially in subjects with low CAD probability. Such an
approach might ultimately reduce the number of normal
SPECT scans performed. To validate this further and to
explore the potential clinical utility of BAUS-based screen-
ing, future prospective studies comparing BAUS to ExMPI
using a predefined cut-point (10% in our series of subjects)
are warranted.
Exercise capacity and endothelial function. Exercise ca-
pacity in patients with known or suspected CAD is helpful
for prognosis (22). While it is known that regular exercise
can prevent the age-associated decline in EDV and can
attenuate reductions in arterial compliance (23,24), no prior
study has determined whether endothelial function is asso-
ciated with exercise capacity. The present data indicate that
changes in brachial artery diameter may potentially be
related to exercise performance. Among all subjects, those
with decreased FMD exhibited significantly shorter exercise
duration than those with a larger FMD. In the subset of
individuals with normal nuclear scans, exercise time was also
shorter in subjects with an FMD 10% when compared
with those with an FMD 10%. In addition, subjects with
an FMD 10% exercised for approximately the same
duration regardless of whether the ExMPI was positive or
negative. We believe this is the first study showing a
possible correlation between EDV and exercise capacity, an
important physiologic marker and predictor of cardiovascu-
lar events. Further studies focusing on endothelial function
and exercise ability are needed.
Study limitations. Several limitations of this study deserve
comment. First, we compared BAUS to ExMPI, not to
coronary angiography or intravascular ultrasound. While
these invasive techniques are considered the gold standard
for detection of CAD, ExMPI has evolved into a reliable
and frequently used technique for detecting CAD. Exercise
myocardial perfusion imaging allows for an assessment of
the physiologic relevance of coronary artery stenosis and for
the evaluation of a broader subject population than would be
encountered in an angiographic study, especially in lower
risk individuals of interest for this study. The sensitivity of
ExMPI, however, is approximately 90%, and, though some
patients with obstructive CAD may have been missed in
this study, this is likely a small number and is unlikely to
have significantly altered the findings. Second, assessment
of cardiac risk factors is inherently imperfect because some
individuals were undergoing treatment with medications
while others were not. We inquired only about traditional
cardiac risk factors and did not examine “novel” risk factors,
which might play a role in endothelial function and athero-
sclerosis. For example, hyperhomocysteinemia or elevated
C-reactive protein levels have been shown to inhibit periph-
eral arterial vasoreactivity (25,26) but were not tested in this
patient population. It is also possible that differences in the
distribution of risk factors (or gender) between the positive
and negative ExMPI groups could also have contributed to
the differences observed in FMD. However, the trend
toward more risk factors in the positive ExMPI group was
not statistically significant, and, though there were fewer
women in the positive ExMPI group, there was not a
significant difference in FMD between men and women.
Third, it is possible that age is related to the observed
relationship between the decline in exercise performance
and abnormalities in endothelial function. It is known that
FMD decreases with the normal aging process. However, in
subgroup analysis, age did not appear to be a significant
confounding variable for duration of exercise time. Thus,
older age does not fully explain the decrease in exercise time
in those with abnormal endothelial function. In addition, it
is likely that exercise itself can acutely affect endothelial
function. In order to ensure that exercise itself did not
change vasomotor tone, FMD was evaluated at least 2 h
after the cessation of treadmill exercise. Finally, while our
results indicate an FMD cut-point of 10%, this may not be
applicable to other laboratories performing BAUS because
of the lack of standardization of this methodology (27). At
Table 4. Exercise Treadmill Time and Flow-Mediated Dilation
FMD <10% FMD >10% p Value
Exercise time (s), all subjects 456  24 544  31 0.02
Exercise time (s), negative
ExMPI subjects
444  29 547  32 0.02
Mean  standard error.
ExMPI  exercise myocardial perfusion imaging; FMD  flow-mediated dilation.
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this point, there is no uniformly accepted technique for
performing BAUS, and there is a wide variability in normal
ranges between laboratories. This is based on certain tech-
nical aspects of the procedure, such as cuff position and
duration of vessel occlusion, which can alter the degree of
FMD. We chose to perform upper arm occlusion because of
the larger percent FMD that can be achieved and, thus, the
larger differences between groups being studied.
Conclusions. These results support the notion that evalu-
ation of peripheral vascular endothelial function can accu-
rately exclude CAD in subjects undergoing noninvasive
assessment for atherosclerosis. Determination of peripheral
endothelial function can confirm a low probability of CAD
in low-risk individuals and, thus, may obviate the need for
more elaborate testing. For those in whom abnormal EDV
is detected, further evaluation with techniques such as
ExMPI appears warranted. Peripheral vascular function
testing may also provide information regarding exercise
capacity and the impact of cardiac risk factors on arterial
function. If further prospective studies with larger popula-
tions confirm these findings, BAUS may become useful as a
screening tool for excluding CAD in lower risk subjects
undergoing evaluation for suspected CAD.
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